Preclinical CROs in China

6 contract research organizations in our directory list a site in China. 3 report GLP capability and 3 report AAALAC accreditation. Compare services, species and accreditations below, and contact labs directly from their profiles.

6 CROs 3 GLP 3 AAALAC

Preclinical research in China

China has grown into one of the largest centers of preclinical capacity, with integrated discovery providers and large toxicology facilities offering rodent, dog and nonhuman primate studies, often with competitive timelines and pricing.

Laboratories are certified for GLP by China’s National Medical Products Administration (NMPA). China is not a full adherent to the OECD Mutual Acceptance of Data system, so for studies intended to support a US or EU filing, ask about the facility’s FDA or OECD-country inspection history and how the data will be presented to your regulator.

Among the CROs listed in China, the most common services are Toxicology, Surgery, Pharmacokinetics and Histology. The species they most often work with are Cynomolgus monkey, Rhesus monkey and Mouse.

Preclinical CROs in China

Showing 6 CROs with a site in China. Order rotates daily so no lab is permanently listed first.

NeuroBridge

Guangzhou Verified GLP AAALAC

NeuroBridge Biotechnology is a specialized preclinical research organization based in Guangzhou, China, focused on non-human primate (NHP) and pig disease models and exploratory non-GLP translational studies. We support…

AAV Biodistribution Acute Toxicity ADME Studies Behavioral Assessment Biodistribution Cynomolgus monkey Minipig Non-human Primate Rhesus monkey

Medicilon

Shanghai GLP AAALAC
Bioanalysis Toxicology Dog Mouse Non-human Primate Rabbit

WuXi AppTec

CN Verified GLP AAALAC

Global R&D services including discovery, DMPK, toxicology, bioanalysis, and manufacturing support.

Bioanalysis Histology Pharmacokinetics Surgery Toxicology Cynomolgus monkey Dog Mouse Pig

Questions to ask a CRO in China

  • Will the study run at the site in China, or could work be moved to another of your facilities?
  • How do you receive test article shipments, and what import permits or customs paperwork do you handle?
  • Can our team visit the facility before the study starts and during critical phases?
  • Which regulators and GLP monitoring authorities have inspected this site, and when?
  • What is your current lead time for our species at this site?

For a full checklist, see our CRO selection guide.